Zherui Liu

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Clinical characteristics and outcomes in 50 children with autoimmune hepatitis: a retrospective study from a single centre in China.

Clinical characteristics and outcomes in 50 children with autoimmune hepatitis: a retrospective study from a single centre in China.

Journal: Frontiers in medicine

Published: October 27, 2025

NLRP6 deficiency enhances macrophage-mediated phagocytosis via E-Syt1 to inhibit hepatocellular carcinoma progression.

NLRP6 deficiency enhances macrophage-mediated phagocytosis via E-Syt1 to inhibit hepatocellular carcinoma progression.

Journal: Gut

Published: November 29, 2024

Analysis of Immunometabolic Profiles in Patients With Chronic Drug-Induced Liver Injury and Validation in Mice to Reveal Potential Mechanisms.

Analysis of Immunometabolic Profiles in Patients With Chronic Drug-Induced Liver Injury and Validation in Mice to Reveal Potential Mechanisms.

Journal: Journal of gastroenterology and hepatology

Published: August 17, 2024

Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAs.

Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAs.

Journal: International journal of nanomedicine

Published: July 09, 2024

An optimized short-term steroid therapy for chronic drug-induced liver injury: A prospective randomized clinical trial.

An optimized short-term steroid therapy for chronic drug-induced liver injury: A prospective randomized clinical trial.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: November 29, 2023

Degradation of FAK-targeting by proteolytic targeting chimera technology to inhibit the metastasis of hepatocellular carcinoma.

Degradation of FAK-targeting by proteolytic targeting chimera technology to inhibit the metastasis of hepatocellular carcinoma.

Journal: Oncology research

Published: September 24, 2023

NLRP6 deficiency suppresses colorectal cancer liver metastasis growth by modulating M-MDSC-induced immunosuppressive microenvironment.

NLRP6 deficiency suppresses colorectal cancer liver metastasis growth by modulating M-MDSC-induced immunosuppressive microenvironment.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: September 08, 2023

Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives.

Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives.

Journal: Frontiers in pharmacology

Published: October 23, 2022

Comparison of hepatitis B virus reactivation in hepatocellular carcinoma patients who received tyrosine kinase inhibitor alone or together with programmed cell death protein-1 inhibitors.

Comparison of hepatitis B virus reactivation in hepatocellular carcinoma patients who received tyrosine kinase inhibitor alone or together with programmed cell death protein-1 inhibitors.

Journal: Hepatology international

Published: September 15, 2022

Development and Validation of a nomogram for forecasting survival of alcohol related hepatocellular carcinoma patients.

Development and Validation of a nomogram for forecasting survival of alcohol related hepatocellular carcinoma patients.

Journal: Frontiers in oncology

Published: June 24, 2022

An OX40L mRNA vaccine inhibits the growth of hepatocellular carcinoma.

An OX40L mRNA vaccine inhibits the growth of hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: June 22, 2022

Intestinal Candida albicans Promotes Hepatocarcinogenesis by Up-Regulating NLRP6.

Intestinal Candida albicans Promotes Hepatocarcinogenesis by Up-Regulating NLRP6.

Journal: Frontiers in microbiology

Published: November 19, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026